{
    "code": "02023808",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023808",
    "time": "2022-06-17 03:48:19",
    "許可證字號": "衛署藥輸字第023808號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/08\/27",
    "發證日期": "92\/08\/27",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202380803",
    "中文品名": "艾瑞莎 膜衣錠２５０公絲",
    "英文品名": "IRESSA FILM-COATED TABLETS 250MG",
    "適應症": "IRESSA適用於先前已接受過化學治療後，但仍局部惡化或轉移之肺腺癌病患之第二線用藥。IRESSA適用於具有EGFR-TK突變之局部侵犯性或轉移性之非小細胞肺癌(NSCLC)病患之第一線治療。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "GEFITINIB",
    "限制項目": "02輸　入",
    "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
    "申請商地址": "台北市大安區敦化南路二段207號21樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0526000  NIPRO PHARMA CORPORATION KAGAMIISHI PLANT",
            "製造廠廠址": "428, OKANOUCHI, KAGAMIISHI-MACHI, IWASE-GUN, FUKUSHIMA, JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FGB0053000  ASTRAZENECA UK LIMITED",
            "製造廠廠址": "SILK ROAD BUSINESS PARK,MACCLESFIELD,CHESHIRE,SK10 2NA, UK",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "分包裝廠"
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000600",
            "成分名稱": "GEFITINIB",
            "含量描述": "",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "圓形兩面凸出膜衣錠",
        "特殊劑型": "",
        "顏色": "棕色",
        "特殊氣味": "",
        "刻痕": "無",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "023808-Iressa 250mg Tab-Tab-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023808&Seq=441&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "IRESSA ZH TW printed PI 202009-110-04-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023808&Seq=048&Type=9"
        },
        {
            "title": "IRESSA-外盒-P045662-108-05-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023808&Seq=006&Type=8"
        },
        {
            "title": "IRESSA-鋁箔-P012306-108-04-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023808&Seq=005&Type=8"
        },
        {
            "title": "IRESSA-外盒-P045662-108-04-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023808&Seq=004&Type=8"
        },
        {
            "title": "023808-Iressa 250mg Tab-carton 3-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023808&Seq=003&Type=8"
        }
    ]
}